Skip to main content
. 2022 May 25;46(3):417–426. doi: 10.4093/dmj.2022.0106

Fig. 2.

Fig. 2.

Trends in the use of antidiabetic medications in adults with diabetes mellitus from the Korean National Health Insurance Service (NHIS) data, 2002 to 2018. SGLT2i, sodium-glucose cotransporter 2 inhibitor; GLP-1 RA, glucagon-like peptide-1 receptor agonist; DPP-4i, dipeptidyl pepdiase-4 inhibitor; TZD, thiazolidinedione; AGI, α-glucosidase inhibitor; SU, sulfonylurea; GLN, glinide.